Related Experiment Videos
[Warfarin fetopathy]
C Bony1, F Zyka, I Tiran-Rajaofera
1Service de réanimation néonatale, CHD Félix-Guyon, 97405 Saint-Denis, La Réunion, France.
Insights
Warfarin embryopathy, a condition affecting fetuses exposed to vitamin K antagonists, presents with distinct developmental abnormalities. This case highlights chondrodysplasia punctata and facial dysmorphism in an infant exposed to acenocoumarol.
Area of Science:
- Teratology
- Developmental Biology
- Pharmacology
Background:
- Vitamin K antagonists, such as warfarin and acenocoumarol, are crucial for managing thromboembolic conditions during pregnancy.
- However, fetal exposure can lead to a spectrum of congenital abnormalities known as warfarin embryopathy.
- Understanding the risks and mechanisms is vital for informed clinical decision-making.
Observation:
- A neonate exposed in utero to acenocoumarol presented with classic signs of warfarin embryopathy.
- Clinical manifestations included chondrodysplasia punctata with telebrachydactyly, facial dysmorphism (nasal hypoplasia), cataracts, and bilateral pyeloureteral junction syndrome.
- These findings underscore the teratogenic potential of vitamin K antagonists.
Findings:
- Warfarin embryopathy affects over 6% of fetuses exposed to vitamin K antagonists in utero.
- The observed anomalies represent a significant burden of disease, impacting multiple organ systems.
- This case reinforces the diagnostic criteria for this drug-induced embryopathy.
Implications:
- The case highlights the critical need for careful risk-benefit assessment when prescribing anticoagulants during pregnancy.
- Further research into fetal vitamin K metabolism may elucidate the precise mechanisms underlying warfarin embryopathy.
- Enhanced awareness among healthcare providers is essential for preventing and managing this condition.
Unlabelled:
We report a case of warfarin embryopathy. This disease affects more than 6% of fetuses exposed in utero to a vitamin K antagonist.
Observation:
A child whose mother was treated with acenocoumarol because of a mechanical heart valve presented with signs of warfarin embryopathy. He showed chondrodysplasia punctata with telebrachydactyly, facial dysmorphism with nasal hypoplasia, a cataract, and a bilateral pyeloureteral junction syndrome.
Comments:
Characteristics of this drug induced embryopathy are reminded, while bearing in mind the conflict of interests between the mother and the fetus. The mechanisms of this embryopathy are debated in light of the recent knowledge concerning fetal metabolism of vitamin K.